Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.

Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG; Protégé Trial Investigators..

Lancet. 2011 Aug 6;378(9790):487-97. doi: 10.1016/S0140-6736(11)60931-8. Epub 2011 Jun 28.

2.

Synthesis and immunological activity of mono- and disubstituted derivatives of 2,5-dimercapto-1,3,4-thiodiazoles.

Kowalczyk-Bronisz SH, Pomorski J, Bubak B, Pregiel M, Błaszczyk B.

Arch Immunol Ther Exp (Warsz). 1995;43(3-4):199-205.

PMID:
8744696
3.

Studies on the effect of organophosphorus pesticide phosalone on mouse immune system.

Kowalczyk-Bronisz SH, Kotz J, Bubak B, Pregiel M.

Arch Vet Pol. 1994;34(3-4):221-30.

PMID:
8891176

Supplemental Content

Loading ...
Support Center